The Regenosome Tech Forum 2026 celebrated the achievements of the past two years, with insights on future projects and advancements in longevity science.

Regenosome, a longevity tech venture, showcased pioneering research on nanoparticles at GATEWAY Tech TAKANAWA 2026, revealing its potential for longevity and brain delivery.

Regenosome is competing in LA-Bench 2025, an AI-driven lab automation competition aimed at revolutionizing life sciences experiment design.

Regenerative technology firm Regenosome has been selected for a defense innovation project aimed at predicting societal dynamics through cutting-edge technology.

This article discusses the recent launch of a jointly conducted hypoxic wellness testing initiative between Regenosome Inc. and Tohoku University, highlighting its significance.

Regenosome and Skypharma have established a joint research agreement to explore innovative treatments for age-related and neurodegenerative diseases using low-molecular-weight compounds.

Regenosome, a subsidiary of Space Seed Holdings, will present groundbreaking aging care products at JFEX SUMMER 2025 in Tokyo from July 9-11.

Regenerative nutrition meets science with the launch of SAISEI supplement by Regenosome, aiming for wellness and aging care innovation.